Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2008 1
2009 2
2010 3
2012 3
2013 6
2014 1
2015 2
2016 6
2017 6
2018 6
2019 4
2020 7
2021 11
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.
Woroniecka K, Chongsathidkiet P, Rhodin K, Kemeny H, Dechant C, Farber SH, Elsamadicy AA, Cui X, Koyama S, Jackson C, Hansen LJ, Johanns TM, Sanchez-Perez L, Chandramohan V, Yu YA, Bigner DD, Giles A, Healy P, Dranoff G, Weinhold KJ, Dunn GP, Fecci PE. Woroniecka K, et al. Among authors: chandramohan v. Clin Cancer Res. 2018 Sep 1;24(17):4175-4186. doi: 10.1158/1078-0432.CCR-17-1846. Epub 2018 Feb 7. Clin Cancer Res. 2018. PMID: 29437767 Free PMC article.
Author reply Re: Chandramohan V, Siddalingaswamy PM, Ramakrishna P, Soundarya G, Manas B, Hemnath A. Retrograde Intrarenal Surgery for renal stones in children <5 years of age. Indian J Urol 2021;37:48-53.
Chandramohan V, Siddalingaswamy PM, Paidakula R, Ganesan S, Manas B, Anandan H. Chandramohan V, et al. Indian J Urol. 2021 Apr-Jun;37(2):202-203. doi: 10.4103/iju.IJU_53_21. Epub 2021 Apr 1. Indian J Urol. 2021. PMID: 34103813 Free PMC article. No abstract available.
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition.
Low JT, Chandramohan V, Bowie ML, Brown MC, Waitkus MS, Briley A, Stevenson K, Fuller R, Reitman ZJ, Muscat AM, Hariharan S, Hostettler J, Danehower S, Baker A, Khasraw M, Wong NC, Gregory S, Nair SK, Heimberger A, Gromeier M, Bigner DD, Ashley DM. Low JT, et al. Among authors: chandramohan v. Cancer Cell. 2022 May 9;40(5):439-440. doi: 10.1016/j.ccell.2022.04.009. Epub 2022 Apr 28. Cancer Cell. 2022. PMID: 35487217 No abstract available.
Toxin-based targeted therapy for malignant brain tumors.
Chandramohan V, Sampson JH, Pastan I, Bigner DD. Chandramohan V, et al. Clin Dev Immunol. 2012;2012:480429. doi: 10.1155/2012/480429. Epub 2012 Feb 9. Clin Dev Immunol. 2012. PMID: 22400035 Free PMC article. Review.
Th17 Immunity in the Colon Is Controlled by Two Novel Subsets of Colon-Specific Mononuclear Phagocytes.
Huang HI, Jewell ML, Youssef N, Huang MN, Hauser ER, Fee BE, Rudemiller NP, Privratsky JR, Zhang JJ, Reyes EY, Wang D, Taylor GA, Gunn MD, Ko DC, Cook DN, Chandramohan V, Crowley SD, Hammer GE. Huang HI, et al. Among authors: chandramohan v. Front Immunol. 2021 Apr 28;12:661290. doi: 10.3389/fimmu.2021.661290. eCollection 2021. Front Immunol. 2021. PMID: 33995384 Free PMC article.
Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor.
Pandian SRK, Pavadai P, Vellaisamy S, Ravishankar V, Palanisamy P, Sundar LM, Chandramohan V, Sankaranarayanan M, Panneerselvam T, Kunjiappan S. Pandian SRK, et al. Among authors: chandramohan v. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):735-749. doi: 10.1007/s00210-020-02015-9. Epub 2020 Nov 6. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 33156389
55 results